Koru Medical Systems, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
KORU Medical Systems reports an 18% increase in net revenues for the year ended December 31, 2024, driven by growth in core domestic and international businesses and novel therapies.
NASDAQ
Koru Medical Systems experienced a slight revenue increase in 2023, driven by core business growth, but faced a larger net loss due to a deferred tax asset valuation allowance.